NDC 70771-1325

NDC codes

FDA NDC Directory

Product NDC (as listed)70771-1325Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70771-1325Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
70771-1325-0	70771132500	1000 TABLET in 1 BOTTLE (70771-1325-0)Marketed from Apr 14, 2018
70771-1325-1	70771132501	100 TABLET in 1 BOTTLE (70771-1325-1)Marketed from Apr 14, 2018
70771-1325-3	70771132503	30 TABLET in 1 BOTTLE (70771-1325-3)Marketed from Apr 14, 2018
70771-1325-4	70771132504	10 BLISTER PACK in 1 CARTON (70771-1325-4) / 10 TABLET in 1 BLISTER PACK (70771-1325-2)Marketed from Apr 14, 2018
70771-1325-9	70771132509	90 TABLET in 1 BOTTLE (70771-1325-9)Marketed from Apr 14, 2018

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): candesartan cilexetil and hydrochlorothiazide
Generic name (nonproprietary): candesartan cilexetil and hydrochlorothiazide
Active ingredients: Candesartan cilexetil — 16 mg/1Hydrochlorothiazide — 12.5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Zydus Lifesciences Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203466
Marketing start: Apr 14, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Angiotensin 2 Receptor Antagonists (Mechanism)Increased Diuresis (Physiologic effect)Thiazides (Chemical structure)
Identifiers: Product ID 70771-1325_2b38d778-d732-4a7b-bb34-b426a14e10bcSPL ID 2b38d778-d732-4a7b-bb34-b426a14e10bcSPL set ID cb328bc1-5738-4620-b2b3-442e98388a86RxCUI 578325, 578330, 802749UNII R85M2X0D68, 0J48LPH2TH
Pharmacologic class: Angiotensin 2 Receptor Blocker; Thiazide Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470771132500 followed by a unit qualifier and the quantity

Package 70771-1325-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 11, 2024.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 203466

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203466
Product	Strength	Form · route	Labeler	Product NDC
candesartan cilexetil and hydrochlorothiazide	Candesartan cilexetil 32 mg/1; Hydrochlorothiazide 12.5 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1326
candesartan cilexetil and hydrochlorothiazide	Candesartan cilexetil 32 mg/1; Hydrochlorothiazide 25 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1327

candesartan cilexetil and hydrochlorothiazide NDC 70771-1325